Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-24-002381
Filing Date
2024-01-08
Accepted
2024-01-08 21:13:31
Documents
1
Period of Report
2024-01-04

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm242462-10_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm242462-10_4seq1.xml 4 9500
  Complete submission text file 0001104659-24-002381.txt   10977
Mailing Address C/O FOREST LABORATORIES, INC. 909 THIRD AVENUE NEW YORK NY 10022
Business Address
Weinstein Herschel S (Reporting) CIK: 0001349008 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39044 | Film No.: 24521575

Mailing Address 100 WASHINGTON BOULEVARD STAMFORD CT 06902
Business Address 100 WASHINGTON BOULEVARD STAMFORD CT 06902 203-883-9490
SpringWorks Therapeutics, Inc. (Issuer) CIK: 0001773427 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)